Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors
収録刊行物
-
- Cancer and Metastasis Reviews
-
Cancer and Metastasis Reviews 18 (4), 473-481, 1999
Springer Science and Business Media LLC